FIELD: medicine.
SUBSTANCE: invention relates to medicine and viral infection treatment, particularly combined antiviral agent with anti-HIV action, namely the combined antiviral agent, comprising the composition of (2R, cis)-4-amino-1-(2-hydroxymethyl-1,3-oxathiolane-5-yl)-1H-pyrimidine-2-on (lamivudine) and 5'-H-phosphonate-3'-azido-3'-desoxythymidine sodium salt (phosphazide) in 250:1 to 1:250 weight ratio, and the treatment for HIV-infection method.
EFFECT: producing of combined antiviral agent with anti-HIV action, providing the increase in treatment effectiveness along with significant reduction of toxic manifestations.
12 cl, 2 tbl, 7 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMBINATION OF ANTIVIRAL AGENTS, KIT AND METHOD OF TREATMENT BASED THEREON | 2018 |
|
RU2726210C2 |
| 5'-PHOSPHORUS-CONTAINING DERIVATIVES OF 2',3'-DIDEOXY-3'-THIACYTIDINE - NEW ANTIVIRAL AGENTS | 2007 |
|
RU2373218C2 |
| NOVEL DEPOT-FORMS OF ZIDOVUDINE AND LAMIVUDINE BASED ON PHOSPHONIC ACID DERIVATIVES | 2009 |
|
RU2430104C1 |
| URETHANE AZT DERIVATIVES - POTENTIAL ANTIVIRAL AGENTS | 2009 |
|
RU2430103C1 |
| 3'-AZIDO-3'-DEOXYTHYMIDINE 5'-CHOLINE PHOSPHATE AS ANTIVIRAL AGENT | 2002 |
|
RU2293739C2 |
| 5'-AMINOCARBONYLPHOPHONATE 3'-AZIDO-3'-DEOXYTHYMIDINE SALTS BEING SELECTIVE INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS HIV-1 | 2010 |
|
RU2441016C1 |
| METHOD OF PRODUCING 5'-AMINOCARBONYLPHOSPHONATES OF NUCLEOSIDES AND METHOD OF PRODUCING ACYL CHLORIDE OF TRIMETHYLSILYL ETHER OF ETHOXYCARBONYLPHOSPHONIC ACID | 2010 |
|
RU2446169C2 |
| DERIVATIVES OF 3'-AZIDO-3'-DEOXYTHYMIDINE 5'-H-PHOSPHONATE AND PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF | 2001 |
|
RU2187509C1 |
| NUCLEOSIDE ANALOG PHOSPHORAMIDATES AS INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPRODUCTION | 2003 |
|
RU2243972C1 |
| COMPOSITION WITH ANTI-RETROVIRAL ACTIVITY, PHARMACEUTICAL COMPOSITION AND DRUG | 2020 |
|
RU2753518C1 |
